Armistice Capital, LLC Volitionrx LTD Transaction History
Armistice Capital, LLC
- $6.56 Billion
- Q1 2025
A detailed history of Armistice Capital, LLC transactions in Volitionrx LTD stock. As of the latest transaction made, Armistice Capital, LLC holds 8,206,430 shares of VNRX stock, worth $6.07 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
8,206,430
Previous 8,481,895
3.25%
Holding current value
$6.07 Million
Previous $5.09 Million
8.1%
% of portfolio
0.07%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding VNRX
# of Institutions
24Shares Held
21.3MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY10.2MShares$7.54 Million3.7% of portfolio
-
Geode Capital Management, LLC Boston, MA762KShares$563,8430.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA706KShares$522,4840.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$381,8940.0% of portfolio
-
Silverberg Bernstein Capital Management LLC Armonk, NY201KShares$148,5780.1% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $42.4M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...